Mercado mundial de desmopresina: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de desmopresina

La desmopresina se utiliza para tratar una amplia variedad de afecciones médicas, entre las que se incluyen la poliuria nocturna, la diabetes insípida, la hemofilia A, la enfermedad de Willebrand y el sangrado urémico. La creciente incidencia de la diabetes insípida entre las personas y el aumento de los episodios de enuresis en los niños han creado un mercado exitoso para el acetato de desmopresina a nivel mundial. Se prevé que los fabricantes de acetato de desmopresina mejoren su presencia regional de productos junto con numerosas actividades promocionales, como programas de concienciación sobre las medidas para prevenir la enuresis nocturna y el tratamiento de la diabetes insípida.

Data Bridge Market Research analiza la tasa de crecimiento del mercado de la desmopresina en el período de pronóstico 2023-2030. La CAGR esperada del mercado de la desmopresina tiende a rondar el 5,8% en el período de pronóstico mencionado. El mercado se valoró en USD 1055,63 millones en 2022 y crecería hasta USD 1657,28 millones para 2030. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de desmopresina

Market Definition

Desmopressin is a type of vasopressin and is widely used to replace a low level of vasopressin. The desmopressin medication aids in controlling the rising urge of urination and dehydration. It has also been used to control night-time bedwetting in children. Furthermore, in conditions such as diabetes insipidus, wherein the body produces an abnormally large amount of urine, desmopressin medicines have been used widely.

Desmopressin Market Dynamics

Drivers

• Growing Prevalence of Diabetes

The number of people suffering from diabetes rise from 108 million in 1980 to 422 million in 2014. Prevalence has increased rapidly in low and middle-income countries compared to high-income countries. Between 2000 and 2019, there was a 3% increase in diabetes mortality rates by age. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths. Numerous studies have shown that zinc improves glucose levels in people suffering from diabetes. This leads to the market growth.

• Increased Awareness About the Diseased Conditions

The developing research associated with the market increases the expansion rate during the forecast period. The more adoption of clinical drugs for this diseased condition will bring much favourable outcomes. Furthermore, the treatment involves both counseling sessions and drugs. Therefore, the market tends to grow at a fast pace considering both the options.

Opportunities

• Increasing Investments by Several market Players

There have been rising investments by multiple market players that are helping boost the market's growth. For instance, in September 2017, Amring Pharmaceuticals announced its plans to invest in desmopressin acetate to meet its commitment of providing high-quality generic medicines and excellent customer service at a reasonable price.

Restraints/Challenges

• Side-Effects of Antipsychotic Drugs

Desmopressin can show major complications. Heavy dosage of this drug can cause flushing, nausea, transient headache, and mild abdominal cramps. This hampers the market growth.

This desmopressin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the desmopressin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Desmopressin Market Scope

The desmopressin market is segmented on the basis of form, applications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Form

• Injectable Solution
• Nasal Spray
• Tablet

Applications

• Paediatric Use
• Geriatric Use

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Desmopressin Market Regional Analysis/Insights

The desmopressin market is analyzed and market size insights and trends are provided by form, applications, distribution channel and end-user as referenced above.

The major countries covered in the desmopressin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will expect the highest growth for the desmopressin market throughout the forecasted period due to increased new research and developments on the desmopressin market.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Desmopressin Market Share Analysis

El panorama competitivo del mercado de la desmopresina proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de la desmopresina.

Los actores clave que operan en el mercado de la desmopresina incluyen:

• Pfizer Inc (Estados Unidos)
• Industrias farmacéuticas Teva Ltd (Israel)
• NorthStar Rx LLC (Estados Unidos)
• Industrias farmacéuticas Sun Ltd. (India)
• avenit AG (China)
• Ferring BV (Suiza)
• Amring Pharmaceuticals Inc. (Estados Unidos)
• Apotex Inc (Canadá)
• Glenmark Pharmaceuticals Ltd (India)
• Mylan NV (Estados Unidos)

SKU-57349